Trials / Sponsors / Ebima Clifford Okundaye
Ebima Clifford Okundaye
Industry · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Use of QRX3 for Acute Tubular Necrosis Type of Renal Failure in Hospitalized Patients ( QRX-3 in ARF) Acute Renal Failure (ARF), Acute Tubular Necrosis | Phase 2 / Phase 3 | 2026-06-30 |
| Not Yet Recruiting | Use of New Drug QRX-3 for Prevention and Treatment of Chronic Kidney Disease Progression Chronic Kidney Diseases, Acute Kidney Injury, Kidney Failure | Phase 2 / Phase 3 | 2025-10-01 |
| Completed | Role of QRX-3 in Chronic Kidney Disease Patients in Outpatients Clinics Chronic Kidney Disease Stages 3-5, Diabetic Kidney Disease, Hypertensive Kidney Disease | Phase 2 | 2023-03-01 |